================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 7, 2004 Date of Report (Date of earliest event reported) ORAGENICS, INC. (Exact name of registrant as specified in its charter) Florida 000-50614 59-3410522 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 12085 Research Drive Alachua, Florida 32615 (Address of principal executive offices including zip code) (386) 418-4018 Registrant's telephone number, including area code - -------------------------------------------------------------------------------- None - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report.) - -------------------------------------------------------------------------------- ================================================================================ ITEM 7.01 REGULATION FD DISCLOSURE Oragenics, Inc. announces that it will de-list its common stock from the TSX Venture Exchange and solely list its shares on the American Stock Exchange. ITEM 9.01 FINANCIAL INFORMATION AND EXHIBITS ----------------------------------------- Exhibit No. Description ----------------------------------------- 99.1 Press Release ----------------------------------------- SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 7th day of October, 2004. ORAGENICS, INC. (Registrant) BY: /s/ Mento A. Soponis Mento A. Soponis President and Chief Executive Officer